Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Pharm-Rx Dextromethorphan

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    Topscience Biotech specializes in R&D, production, and sales of Sodium Hyaluronate, focusing on Medical and Pharmaceutical Grade HA.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Menu

    Koffex DM

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 184Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axsome FDA Pre-NDA Minutes Support AXS-05 Filing In AD Agitation
    Axsome FDA Pre-NDA Minutes Support AXS-05 Filing In AD Agitation

    03 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/03/3035463/33090/en/Axsome-Therapeutics-Announces-FDA-Pre-NDA-Meeting-Minutes-for-AXS-05-in-Alzheimer-s-Disease-Agitation-Supporting-NDA-Submission.html

    GLOBENEWSWIRE
    03 Mar 2025
    Share Share
    Teva agrees with Axsome to keep generic off market until 2038
    Teva agrees with Axsome to keep generic off market until 2038

    11 Feb 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/axsome-shares-jump-21-settlement-teva-will-keep-auvelity-generic-market-until-2038

    FIERCE PHARMA
    11 Feb 2025
    Share Share
    Axsome Advances Alzheimer's Drug Despite Mixed Trial Data
    Axsome Advances Alzheimer's Drug Despite Mixed Trial Data

    31 Dec 2024

    // BIOSPACE

    https://www.biospace.com/press-releases/axsome-therapeutics-announces-successful-completion-and-results-of-phase-3-clinical-program-of-axs-05-in-alzheimers-disease-agitation

    BIOSPACE
    31 Dec 2024
    Share Share
    Enforcement Report - Week of December 18, 2024
    Enforcement Report - Week of December 18, 2024

    18 Dec 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-18-2024-87175.pdf

    FDA
    18 Dec 2024
    Share Share
    Enforcement Report - Week of November 13, 2024
    Enforcement Report - Week of November 13, 2024

    13 Nov 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-13-2024-31538.pdf

    FDA
    13 Nov 2024
    Share Share
    Wanbury receives CEP certification for Dextromethorphan API from EDQM
    Wanbury receives CEP certification for Dextromethorphan API from EDQM

    09 Sep 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/wanbury-receives-cep-certification-for-dextromethorphan-api-from-edqm/

    EXPRESSPHARMA
    09 Sep 2024
    Share Share